Company / Operating Income per Share
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Operating Income per Share History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.05
FY2015
5-year range
-$0.08 / -$0.03
FY2011-FY2015
Trend
+37.3%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2015 after 2 years of decline, reaching $-0.05.
Based on SEC 10-K filings.
-0.05 in FY2015.
Improved from $-0.07 to $-0.05 over the past 3 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, operating income per share increased 37.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$0.05 | +37.3% |
| FY2013 | -$0.08 | -12.7% |
| FY2012 | -$0.07 | -197.3% |
| FY2011 | -$0.03 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026